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The  two  key  questions  of human  cancer  immunology remain  unresolved.  These 
relate  to whether tumor-specific antigens  exist  in human cancer and,  if so, whether 
there is immunological recognition of these antigens in humans.  To date, candidate 
human tumor-specific antigens defined by heterologous sera have, on further analysis, 
turned out to belong to the category of differentiation antigens, antigens characterizing 
normal cells at some phase of differentiation,  rather than antigens that are restricted 
to neoplastic  cells.  The tumor antigens  that  are  detected  by reactions  with  human 
sera  fall into several categories, with alloantigens  (particularly  products of the HLA 
complex and ABO locus), antigens related to Epstein-Barr virus, and antigens related 
to the heterologous sera used  in culturing human cancer cells  representing  the best 
studied  examples.  In  general,  however,  most  surveys  of  human  populations  for 
humoral or cell-mediated immunity to cell surface or intracellular antigens of human 
cancer cells have not provided the sort of evidence that would permit  the distinction 
of tumor-specific reactions from reactions directed to other categories of antigens. 
To develop as direct  an approach  as possible  to the  question of whether patients 
with cancer recognize tumor-specific antigens on the surface of their cancer cells, we 
have developed a serological approach, referred to as autologous typing, that has been 
applied  to  the  study  of cell  surface  antigens  of malignant  melanoma  (1-3),  acute 
leukemia  (4), and astrocytoma (5).  Autologous typing has several features:  (a)  direct 
tests  are restricted  to reactions between  sera and tumor cells from the same patient, 
eliminating the need to consider reactions that are a  result  of conventional alloanti- 
bodies and assuring the detection of antigens restricted to autologous tumor cells, i.e., 
class  1 antigens,  see below;  (b)  several serological tests are used  in parallel,  reducing 
the possibility that antibody belonging to a particular class might be missed; (c) target 
cells from solid tumors are provided by serially passaged tissue culture lines, permitting 
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repeated tests to be performed (in the case of leukemia, where adequate numbers of 
viable  cells  can  be  obtained  directly  from  the  patient,  target  cells  are  stored  by 
cryopreservation  for repeated  sampling);  and  (d)  absorption  tests  are  relied  on  to 
analyze  the  specificity of the  reactions  observed,  providing  a  way  to  classify  the 
antigens detected. Three classes of surface antigens have been detected by autologous 
typing of melanoma, astrocytoma, and  leukemia.  Class  1 antigens  are restricted  to 
autologous  tumor  cells  and  cannot  be  detected  by absorption  tests  on  normal  or 
malignant cells of any other type, autologous, allogeneic, or xenogeneic. Three class 
1 antigens of melanoma (AU, BD, and BI) and two class  1 antigens of astrocytoma 
(AC and BC)  have been identified in our initial survey of 36 melanoma patients (1- 
3)  and 30 astrocytoma patients (5).  Class 2 antigens are found on autologous as well 
as certain allogeneic tumors, but cannot  be detected on normal cells. Three class 2 
antigens have been defined: the AH antigen of melanoma (2), the serologically related 
AJ  antigen  of astrocytoma  (5),  and  a  leukemia  cell  surface  antigen  detected  by 
autologous  antibody  in  one  patient  in  our  initial  survey of 21  patients  with  acute 
leukemia  (4).  On  the basis of current  evidence, class  1 and class  2  antigens  can be 
considered  tumor-restricted  antigens  capable of eliciting  humoral  immunity  in  the 
autologous host. In contrast, class 3 antigens are not restricted to tumors; they can be 
detected  on  both  normal  and  malignant  cells  of human  and  animal  origin.  The 
complex pattern of antigen occurrence revealed by absorption analysis indicates that 
class  3  antigens  are  a  diverse  and  complex  group,  with  some  antigens  showing 
differentiation characteristics, some alloantigenic characteristics, and some heterospe- 
cific  characteristics  (3).  Antibodies  that  detect  class  3  antigens  are  the  ones  most 
commonly found in patients with cancer and, because in direct tests these antibodies 
can appear to react only with tumor cells, rigorous absorption analysis is necessary to 
distinguish reactions of this sort from reactions detecting class 1 and class 2 antigens. 
Autologous typing of human renal cancer is the subject of the present report. Renal 
cancer can be serially cultured  from the tumors of 10-20% of patients, and this has 
permitted us to apply autologous typing to the study of a significant number of renal 
cancer  patients.  An  important  feature  of  these  studies  with  renal  cancer  is  the 
availability  of cultured  normal  kidney  cells  for  absorption  tests.  This  is  a  unique 
advantage in the study of renal cancer as compared to melanoma and astrocytoma, 
where it has not yet been possible to analyze the normal cellular counterpart. 
Materials and Methods 
Tissue Culture 
RENAL CANCER CELLS.  Sterile tumor specimens were dissected free of adherent normal tissue 
and finely minced in Earle's balanced salt solution (EBSS). 1 The released cells and small tissue 
fragments were treated with 0.25% trypsin (Bacto-trypsin, Difco Laboratories, Detroit, Mich.) 
and 0.02% collagenase  (Worthington Biochemical  Corp., Freehold,  N.J.) for 15-30 min at 37°C 
with continuous  mixing using a  magnetic stirrer.  The resulting cell  suspension  was washed 
three times in  EBSS  and resuspended in  Eagle's minimum essential  medium supplemented 
with  1%  nonessential  amino  acids,  2  mM  glutamine,  0.01 U/ml  insulin  (Eli  Lilly  & Co., 
l Abbreviations  used in this paper: EBSS, Earle's balanced salt solution;  MEM, minimum essentia[ medium; 
FBS, fetal bovine serum; NRK, normal rat kidney;  MHA, mixed hemadsorption; IA, immune adherence; 
C3-MHA, anti-C3 mixed hemadsorption; PA, protein A; VBM, Veronal buffer medium; EBV, Epstein- 
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Indianapolis, Ind.), 100 U/ml penicillin, 100/~g/ml streptomycin, and 20% fetal bovine serum 
(primary minimum essential medium [MEM]). The cells were seeded in Falcon No. 3013  (25 
cm  ~) plastic tissue culture flasks (Falcon Labware, Div. of Becton, Dickinson, & Co., Oxnard, 
Calif.)  and  fed  with  primary MEM  twice a  week.  When cultured epithelial cells  became 
confluent, they were detached and dissociated with 0.25% trypsin and transferred into new 
flasks. Initial subculturing began 2-12 wk after seeding the original specimen. After the third 
subculture, cells were fed twice a week with Eagle's MEM supplemented with 1% nonessential 
amino acids, 2 mM glutamine, 100 U/ml penicillin, 100 #g/ml streptomycin, and 10% fetal 
bovine serum (complete MEM). The frequency of subcuhuring different renal cancer cultures 
ranged  from  once  every  week  to  once  every  4  wk.  Cultures  were  repeatedly  tested  for 
mycoplasma, fungi, and bacteria. Contaminated cultures were discarded. 
Cell lines of renal cancers from  13 patients have been passaged for >10 generations. The 
designations of these renal cancer cell lines are; SK-RC-1  (patient AA), SK-RC-2 (AB), SK- 
RC-3 (AC), SK-RC-4 (AE), SK-RC-5 (AD, SK-RC-6 (AG), SK-RC-7 (AX), SK-RC-8 (BE), 
SK-RC-9 (BM),  SK-RC-10 (BT), SK-RC-11  (BZ),  SK-RC-12  (CA),  and SK-RC-13  (CH). 
Cultures of renal cancer cells that have been passaged < 10 times are designated by the patient 
code. 
NORMAL KIDNEY CELLS.  Normal kidney tissue adjacent to the renal cancer or from nephrec- 
tomies performed for reasons other than malignancy were cultured in the same way as renal 
cancers. As normal kidney cells attach and start to proliferate much faster than renal cancer 
cells, initial subculturing  was usually possible within 1-2 wk. Cultures of fetal kidney cells were 
purchased from Microbiological Associates  (Bethesda, Md.) or were established in our labora- 
tory from kidneys of aborted first trimester fetuses. 
FIBROBLASTS.  Fibroblasts were cultured from biopsied abdominal or arm skin as previously 
described (1). 
OTHER CELL LINES.  For derivation of other cell lines see references  1-6. A line of normal rat 
kidney  (NRK)  was  supplied by  Dr.  P.  O'Donnell, Sloan-Kettering Institute. VERO  and 
BGMK,  two  cell  lines derived  from  monkey kidney, were  obtained from  Microbiological 
Associates. 
Serologial Procedures.  The  mixed hemadsorption assay  (MHA),  immune adherence assay 
(IA), anti-C3 mixed hemadsorption assay (C3-MHA) and protein A assay (PA) were performed 
as previously described (1-3, 5). To reduce the requirement for reagents (serum, target cells, 
and absorbing cells) we have recently adapted these  serological  assays  to Falcon 3034  plates 
(Falcon Labware, Div. of Becton, Dickinson & Co.).  As the modified assay requires five times 
less serum than the standard assay in Falcon 3040 plates (10 #l rather than 50 #l per well) and 
correspondingly less cells for absorption tests, extensive analysis is possible even when the supply 
of sera  and  cultured  cells  is  limited.  Qualitative and  quantitative absorption  tests  were 
performed according to procedures developed in our past work (1-5). Cultures are harvested 
for  absorption tests  by mechanical scraping rather than by exposure to enzymes or EDTA. 
Serum is absorbed at three doubling dilutions below its endpoint (titer).  One aliquot of diluted 
serum remains unabsorbed, whereas other aliquots are mixed with the cells to be tested.  In 
qualitative absorption tests,  0.15  ml of appropriately diluted serum is mixed with 0.1  ml of 
washed packed cells. (For assays in Falcon 3034 plates, 75 #1 of serum and 50/tl of packed cells 
are  used.)  In quantitative absorption tests,  the  diluted serum  is  absorbed with  a  series  of 
increasing numbers of viable cells. Absorption is carried out on ice for  1 h  with occasional 
shaking.  After absorption, the  cells  are  removed by centrifugation, and the  absorbed  and 
unabsorbed sera are tested for residual reactivity with the target cell. 
Rosette Formation with Rat Erythrocytes.  Subconfluent monolayers of cultured cells growing in 
Falcon 3040  plates were prepared.  After removal of the medium, 50 ~tl of a  0.2% (vol/vol) 
suspension of rat erythrocytes in Veronal buffer medium with 5% fetal bovine serum (VBM- 
FBS) were added to each well and the plates left undisturbed for 45 rain at 24°C. The plates 
were then agitated gently, washed once in VBM-FBS, and the attachment of rat erythrocytes 
to the cultured cells was determined by light microscopy. 
Growth 
Culture. 
Results 
Characteristics  and  Morphology  of Renal  Cancer  and  Normal  Kidney  in  Tissue 
Renal cancers from 73 patients were studied. 80% of the renal cancers were RYUZO UEDA ET AL.  567 
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FIc.  1.  Growth characteristics of renal cancer and normal kidney in vitro. 73 specimens of primary 
or  metastatic  renal  cancer  and  43  specimens of normal  kidney  were studied  over a  2-yr  period 
(October,  i976 to December, 1978). 
classified as predominantly clear cell type, the remainder showing mixtures of clear 
cells  and granular or spindle cells.  In 52 cases, primary renal cancers were cultured; 
in  21  cases,  renal  cancer  tissue  came  from  metastatic  sites,  most  commonly lung. 
Cultures of normal kidney cells were derived from normal kidney tissue adjacent to 
renal cancer in the surgical specimens (40 cases)  or from kidneys removed for reasons 
other than malignancy (3 cases).  As shown in Fig.  1, 50% of the primary renal cancers 
could be subcultured at least once and  17% were successfully passaged more than six 
times.  With metastatic renal  cancer, 29%  of the specimens could be subcuhured at 
least  once  and  10%  were  passaged  more  than  six  times.  Two  factors  appear  to 
contribute to the poorer growth of cultures from metastatic renal cancer; more tissue 
is generally obtained from primary renal cancer, resulting in a  larger yield of viable 
cancer cells to initiate cultures, and fibroblast overgrowth was a greater problem with 
specimens  from  metastatic  sites  than  from  the  primary tumor.  Renal  cancers  that 
could be subcultured  for more than  six  times,  whether  from primary or metastatic 
sites,  continued to grow vigorously on subsequent passage. Fig. 2 illustrates  the three 
main cell types that can be distinguished in established cultures of renal cancer. The 
first  type grows as islands of compact epithelial  cells  with irregular, sharply defined 
edges  (Fig.  2A).  The  second  type  exhibits  a  globular  shape  with  pseudopod-like 
structures  (Fig.  2 B).  Although some cultures contained a  preponderance of one cell 
type or the other, most cultures were mixtures of both cell types and, after reaching 
a  confluent state,  the  two cell  types became indistinguishable.  The third  and  least 
common cell type showed a well-defined spindle shape and these cells tended to grow 
in mounds several layers deep (Fig. 2C). Lack of  contact inhibition was a characteristic 
feature of established renal cancer cultures. 
The growth and morphology of cells derived from specimens of normal kidney were 
clearly distinguishable from cultures of renal cancer. Normal kidney cells tend to grow 
more rapidly than renal cancer cells  during initial  culture and a  high percentage of 
normal kidney cultures could be passaged two to three times (Fig.  1). However, after 
passage  2,  the  growth  rate  of normal  kidney cells  fell  sharply,  and  only one  of 43 
cultures could be passaged more than five times. In contrast to the frequent occurrence 
of granules  and  vacuoles  in  the  cytoplasm of renal  cancer cells,  the  cytoplasm of 568  CELL  SURFACE  ANTIGENS OF  HUMAN  RENAL  CANCER 
FIGS.  2 A, B. 
FIG. 2.  Morphology of renal cancer cells and normal kidney cells in vitro (×  160). A-C, cell types 
that  can  he  distinguished  in  cultures of renal  cancer.  D,  characteristic  appearance  of cultured 
normal kidney cells.  (See text for description.) 
normal kidney ceils has few granules or vacuoles. Cultured normal kidney cells have 
a characteristic crescent shape with smooth edges, tend to grown in a whorled pattern, 
and show contact inhibition after a  confluent monolayer is formed (Fig. 2 D). 
Presence of Receptors  for Rat Etythrocytes on the Surface of Renal Cancer and Normal Kidney 
Cells.  During a  search for discriminant  binding of heterologous erythrocytes to the 
surface of cultured human cells, we found that renal cells, both normal and malignant, 
have receptors for rat erythrocytes. Table I shows the range of human cell lines tested 
for  rosette  formation  with  rat  erythrocytes.  All  cultures  of renal  origin  bound  rat 
erythrocytes, whereas 46 lines derived from other sources did not. Two of 10 astrocy- 
toma  lines  were  exceptional  in  having  receptors  for  rat  erythrocytes.  Erythrocytes 
from other species (chicken, mouse, cat, dog, horse, sheep, monkey, and human)  did 
not show specific binding to these cultured cell lines. RYUZO  UEDA ET AL.  569 
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Reactions of Autologous Sera with  Surface Antigens  of Cultured Renal  Cancer Cells.  Sera 
from  28  patients  were tested  for reactivity with  cell surface antigens  of autologous 
renal  cancer cells.  Table II summarizes the  results  of these  tests.  IA assays showed 
that sera from 23 of 28 patients gave positive reactions, with titers ranging from  1/2 
to  1/128.  MHA assays detected a  low titered  reaction in  1 of 22 patients.  C3-MHA 
assays revealed autologous reactions in all 26 patients tested, with titers ranging from 
1/4 to  1/256.  PA assays detected antibodies in  14 of 15 patients, with titers ranging 
from  1/2  to  1/160.  Autologous  reactions detected  by IA and C3-MHA assays were 
generally stronger and higher titered with an incubation of serum and target cells at 
4°C rather than 24°C. In contrast, maximal reactivity in PA assays occurred at 24°C. 
13 of the renal cancers in this series propagated sufficiently well in culture to permit 
further study of autologous  serum  reactivity.  Six of these were chosen  for detailed 
analysis.  To  illustrate  this  analysis, the  results of autologous  typing with  sera  from 
two patients, AG and AX, will be presented. 570  CELL SURFACE  ANTIGENS OF HUMAN RENAL CANCER 
TABLE  I 
Tests  for Rat Erythrocyte Receptors on Cultured Normal and Malignant Cells of Human Origin 
Rosette formation  No rosette formation 
Renal cancer  Astrocytoma  Carcinoma 
SK-RC-1, 2, 3, 4, 6, 7, 8, 9, 10,  AN,  AS,  BAR,  BD,  Bladder,  T-24 
l 1, 12, BL, CP, DA, DY  U138MG,  UI78MG,  Breast, AIAb,  CaMa, MCF-7, 
A-498  U373MG  SK-BR-3 
CaKi- 1  Neuroblastoma  Cervix, ME- 180 
Normal kidney  SK-NMC  Colon, HT-29 
AX, BL, CA, C  J, DB, DF, DH,  SK-NSH  Larynx, HEp-2 
DV, DY  Melanoma  Lung, SK-LC-LL 
Fetal kidney  SK-MEL-13, 14, 19, 25, 27,  Ovary, SK-OV-3 
Astrocytoma  28, 29, 31, 37, 40, 57, 59  Fibroblasts 
AJ, BB  Sarcoma  AI,  AP,  AR,  AT,  AU,  AV, 
SAOS-2  AX, BL, BM, CA 
U2OS  PHEL-6 (fetal) 
WI-38 (fetal) 
Analysis  of Autologous Reactivity  of AG and AX Sera.  The reactivity  of AG and  AX 
sera for autologous renal cancer cells as determined in the four serological test systems 
is  shown  in  Fig.  3.  In both  cases,  antibody was  detected  by PA, C3-MHA,  and  IA 
assays, but not by MHA assays. The reactivity of AG serum was highest in PA assays 
and AX reactivity was highest in C3-MHA assays. These assays were chosen, therefore, 
to analyze AG and AX sera. 
Reactivity  of Sequential Serum Samples for Autologous Renal  Cancer Cells.  Simultaneous 
titrations  of individual  sera from AG and AX collected over a  2-yr period are shown 
in Fig. 4. The reactions of both AG and AX sera remained essentially unchanged over 
this time period. 
Tests  of AX  Sera for  Reactivity  with  Autologous Normal  Kidney  Cells  and  Fibroblasts. 
Fig. 5 shows that AX serum has reactivity for autologous normal kidney cells as well 
as  renal  cancer  cells.  Tests  with  autologous  fibroblasts  were  essentially  negative. 
Comparable tests have been possible with the sera of eight other patients and a similar 
pattern of reactivity for autologous renal cancer cells and normal kidney cells, but not 
fibroblasts,  was seen. 
Qualitative Absorption Analysis of AG and AX Sera.  The reactivity of AG and AX sera 
for autologous renal cancer cells was analyzed by qualitative  absorption  tests.  Fig. 6 
illustrates  individual absorption tests and Tables III and IV summarize the results of 
the analysis. Three patterns of absorption were observed; complete absorption, partial 
absorption,  and no absorption.  In the case of AG, only autologous renal cancer cells 
gave complete  absorption.  In the  case of AX,  autologous  as  well  as  one  allogeneic 
renal cancer (SK-RC-4) completely absorbed reactivity. A limited number of cell lines 
showed  partial  absorption  of AG and  AX reactivity;  these  lines  were derived  from 
cancers of renal  as well as nonrenal  origin.  Astrocytoma AJ partially  absorbed  both 
AG and AX reactivity; other cell lines  (T-24, ME-180, A-498, and SK-RC-9) showed 
partial  absorption  of either  AG  or  AX  reactivity.  No  absorption  of AG  or  AX 
reactivity  for autologous renal  cancer cells  was found with  a  large number of other 
cell types; these tests included allogeneic renal cancer cells, atlogeneic and xenogeneic 
normal kidney cells, fetal kidney cells, and a range of normal and malignant nonrenal 
cells. Absorption tests with AG and AX autologous normal kidney cells could not be RYUZO  UEDA  ET  AL.  571 
TABLE  II 
Survey of Sera  from Patients with Renal Cancer  for Autologous Antibody to Surface Antigens of Cultured 
Renal Cancer Cells: Summary of Serological Tests 
Patient  Age  Sex 
Maximal antibody titer*  Culture 
Stage:~ 
of dis-  genera-  IA  MHA  C3-MHA  PA 
tions 
ease  studied 
4°C§  24°C  4°C  24°C  4°C  24°C  24°C 
AA[I  4I  M  II  51-65  -¶ 
ABI[  59  M  IV  6-31  1/16  1/8 
AC  69  F  III  4  1/2  1/2 
AEII  48  M  II  3-30  1/64  1/32 
AF  50  M  I  2-7  1/32  1/4 
AG  u  72  M  II  1-36  1/4  - 
AI  55  M  III  1-3  >1/64 
A~I  53  F  III  1-14  1/16  1/16 
AR[[  46  M  IV  2-5  -  -- 
AX][  64  M  II  1-40  1/128  1/64 
AZ  69  M  I  1  1/8 
BB  34  F  II  1  - 
BE  47  M  IV  2-15  1/4  1/4 
BI  47  F  II  1-2  1/4  - 
BK  27  M  IV  1-2  1/4  1/8 
BL  73  V  IV  2-13  1/16  118 
BMI[  56  M  IV**  2-28  1/4  1/2 
BU  61  F  III  1  1/8 
BZ  60  M  III  1-13  --  -- 
CA  68  M  IV  2-9  1/32 
CB  57  M  II  I-2  >1/64 
CD  56  F  IV  1-3  l/8  1/2 
CG  62  F  I/  l-3  1/32  1/4 
CH  63  M  IV**  1-11  1/64  1/32 
CI  71  M  II  l-4  - 
CP  64  M  IV  1-6  1/40 
CU  50  M  II  1  1/16 
CV  67  F  II  1-3  1/16 
m 
m 
m 
m 
R 
m 
m 
1/4 
--  >I/64  --  1/40 
--  1/256  1/40  1/40 
-  118  114 
-  1/128  1/32  1/160 
1/64  l/8  1/40 
-  1/32  1/4  1/160 
>1/64 
>1/64  1/16 
--  1/16  1/16 
--  1/256  1/64  1/32 
1/32  1/16 
1/4  1/4  1/8 
--  1/16  1/16 
-  1/16  1/8  -- 
--  1/64  1/32  1/2 
>I/64 
-  1/16  1/4  1/160 
--  1/64  1/64  1/5 
>1/64 
--  1/16  1/2  1/20 
1/64  1/32 
1/64  1/64  1/40 
1/8  >1/64 
1/60  1/20 
1/32  1/4 
1/64 
:[: Stage I: tumor within true renal capsule;  stage II:  tumor invades perinephric fat but is within Gerota's 
fascia; stage III:  tumor involves major renal vein and/or regional lymph nodes without involvement of 
perinephric fat  or  inferior  vena cava;  stage IV:  tumor involvement of adjacent organs  (other than 
adrenal) or distant metastasis,  or both. 
* Titer: highest serum dilution showing 10% positive cells in IA and MHA; 20% positive cells in C3-MHA 
and PA. 
§ Incubation temperature of target cells and serum. 
tl 107 cultured renal cancer cells (>passage 9) were implanted subcutaneously into nu/nu mice. Progressive 
tumor growth was observed in the case of AA, AQ, and AR. 
¶ Signifies no reaction at  1/2 serum dilution. 
** Culture of renal cancer derived from metastatic sites: lung (BM) and brain (CH). 
performed; a  specimen of normal kidney was not obtained  from patient AG, and an 
insufficient number  of normal kidney cells were cultured from patient AX. 
To exclude the participation of antigens related to fetal bovine serum (FBS) in the 
reactions  observed,  the  cell  lines of AG  and  AX  renal  cancer  were  grown  for  five 
passages in medium  supplemented with normal human  serum rather than FBS. These 
cells absorbed autologous reactivity as efficiently as cells grown in FBS. 
Quantitative Absorption Analysis of AG and AX Sera.  To explore the significance of the 572  CELL SURFACE ANTIGENS OF  HUMAN  RENAL CANCER 
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(passage 35) by PA assays. (4 B) AX sera collected over a 25-mo period and tested for autolognus 
reactivity with SK-RC-7 cells (passage 21) by C3-MHA assays. 
partial absorption observed with certain cell lines, AG and AX sera were analyzed by 
quantitative  absorption  tests  (Fig.  7).  Reactivity  of AG  sera  for  autologous  renal 
cancer was completely absorbed  by --  1.8  ×  106 autologous renal cancer cells. Two 
cell  lines  (SK-MEL-27 and.T-24)  that  failed  to absorb  AG reactivity  in  qualitative 
absorption tests were also negative in quantitative  absorption tests over the range of 
cell  numbers  examined.  The  line  of renal  cancer  cells  (A-498)  that  showed  partial 
absorption  in  qualitative  absorption  tests  reduced  AG  reactivity  to  the  same  fixed 
level with 0.12  ×  106 cells as with 8  ×  106 cells. This pattern  of partial  absorption 
indicates  that  A-498 cells  lack one or more of the  determinants  recognized  by AG 
serum on autologous renal cancer cells. 
Quantitative  absorption  analysis of AX serum  showed that  autologous AX renal 
cancer cells  (SK-RC-7)  and  the allogeneic  renal  cancer cell  line  (SK-RC-4)  express 
comparable  amounts  of the  determinant  or set  of determinants  recognized  by AX 
sera on autologous renal cancer cells.  VERO  and DM normal kidney cells absorbed 
little  or no  AX  reactivity  over  the  range  of cell  numbers  tested.  Astrocytoma AJ, RYUZO  UEDA  ET  AL.  573 
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FIa.  5.  Reactivity of AX serum for cultured  autologous  renal cancer cells (SK-RC-7), normal 
kidney cells, and skin fibroblasts, as determined by C3-MHA assays. 
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Fic.  6.  Qualitative absorption analysis of AG and AX sera. (6 A) Individual absorption tests with 
AG sera. AG reactivity for autologous renal cancer cells (SK-RC-6) was completely absorbed by 
SK-RC-6 and partially absorbed by allogeneic renal cancer A-498. Astrocytoma UI38MG, Burkitt 
lymphoma Raji and allogeneic renal cancer SK-RC-1 did not absorb AG reactivity. (6 B) Individual 
absorption tests with AX serum.  AX reactivity for autologous renal cancer cells (SK-RC-7) was 
completely absorbed by SK-RC-7 and allogeneic renal cancer SK-RC-4, and partially absorbed by 
astrocytoma AJ.  VERO, a  cell line derived from monkey kidney, and normal kidney cells from 
patient DM did not absorb AX reactivity. 
comparable to the results obtained in qualitative absorption tests, reduced but did 
not remove AX reactivity at the highest number of AJ cells tested. This capacity of 
astrocytoma AJ  to reduce the reactivity of AX sera could be eliminated by preab- 
sorbing AX serum with astrocytoma AJ.  Fig.  8  represents a  qualitative absorption 
test with AX sera that had been preabsorbed at a  1:1 ratio of undiluted AX serum 
and packed AJ cells. Astrocytoma AJ no longer lowered reactivity of the preabsorbed 
serum,  whereas  SK-RC-9  continued  to  show  partial  absorption.  Fig.  9  shows  a 574  CELL  SURFACE  ANTIGENS  OF  HUMAN  RENAL  CANCER 
TABLE  III 
Analysis  of the PA Reactivity of AG Serum for Autologous Renal Cancer Cells: Summary of Absorption 
Tests 
Complete absorption 
Autologous cultured cells 
SK-RC-6 (AG) 
Partial absorption 
Allogeneic cultured cells: 
SK-RC-7 (AX) 
Ca kidney A-498 
Ast  rocytoma AJ 
No absorption 
Autologous cultured  Ca bladder T-24  Allogeneic noncul- 
cells:  Ca breast AIAb  tured cells: 
Fibroblasts AG  Ca cervix ME-180  AB erythrocytes 
Allogeneic cultured cells:  Ca larynx HEp-2  Xenogeneic  cells  and 
Renal cancer:  Ca lung SK-LC-LL  serum: 
SK-RC-1 (AA)  Melanoma SK-MEL-13  Cultured monkey 
SK-RC-2 (AB)  "  -27  kidney cells: 
SK-RC-9 (BM)  "  -28  VERO 
SK-RC-10 (BT)  "  -40  Rat erythrocytes 
CaKi- 1  Sarcoma U2OS  Sheep erythroeytes 
Normal kidney CI  Sarcoma SAOS-2  Guinea pig kidney 
....  CJ  Burkitt lymphoma Raji  Guinea  pig  spleen 
....  CK  EBV-transformed B cells  cells 
....  CP  BT, CV  Guinea pig brain 
....  CO..  Fetal skin fibroblasts F5  Fetal bovine serum 
....  DB  Fetal kidney cells (6447) 
....  DF 
Astrocytoma 
U 138MG 
TABLE  IV 
Analysis  of the C3-MHA Reactivity of AX Serum for Autologous Renal Cancer Cells: Summary of 
Absorption Tests 
Complete absorption 
Autologous cultured 
cells: 
SK-RC-7 (AX) 
Allogeneic cultured cells: 
SK-RC-4 (AE) 
Partial absorption 
Allogeneic cultured cells: 
SK-RC-9 (BM) 
Astrocytoma AJ 
Ca bladder T-24 
Ca cervix ME- 180 
No absorption 
Autologous cultured  Normal kidney AN  Sarcoma U2OS 
cells:  "  AT  Burkitt lymphoma Raft 
Fibroblasts AX  "  AU  EBV-transformed B- 
EBV-transformed B-  "  AY  cells CV, CX, 
cells AX  "  CI  LM 
Autologous noncultured  "  CJ  Fetal skin fibroblasts F2 
cells:  "  DB  Fetal skin fibroblasts F5 
Erythrocytes  "  DJ  Fetal kidney cells 19 
Lymphoid cells  "  DM  Allogeneic noncultured 
Allogeneic cultured  "  DT  cells: 
cells:  Fibroblasts AG  AB erythrocytes 
Renal cancer:  Astrocytoma U I38MG  Xenogeneic cells and se- 
SK-RC- 1 (AA)  "  U178MG  rum: 
SK-RC-2 (AB)  "  AT  Cultured monkey kid- 
SK-RC-6 (AG)  Ca breast AIAb  ney cells: 
SK-RC-8 (BE)  Ca larynx HEp-2  VERO, BGMK 
SK-RC- 11  (BZ)  Ca lung SK-LC-LL  Cultured rat kidney 
AR  Melanoma SK-MEL- 13  cells: 
CaKi- 1  "  -28  NRK 
CaKi-2  "  -37  Rat erythrocytes 
A-498  "  -40  Sheep erythrocytes 
Guinea pig kidney 
Guinea pig spleen 
cells 
Fetal bovine serum RYUZO UEDA ET AL.  575 
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FIc.  7.  Quantitative absorption analysis of AG and AX sera. (7 A) Aliquots of 1/10 diluted AG 
serum were absorbed with counted numbers of SK-RC-6, A-498, T-24, and SK-MEL-27 cells. The 
absorbed sera were then tested for residual PA reactivity for autologous SK-RC-6 cells. The dotted 
line represents reactivity of unabsorbed 1/10 diluted AG serum. In contrast to complete absorption 
by SK-RC-6, A-498 reduced reactivity to the same fixed level over a  broad range of cell numbers. 
(7 B) Aliquots of 1/8 diluted AX serum were absorbed with counted numbers of SK-RC-7, SK-RC- 
4, astrocytoma A  J,  DM normal kidney, and VERO cells. The absorbed sera were then tested for 
residual C3-MHA reactivity for autologous SK-RC-7 cells. The dotted line represents reactivity of 
unabsorbed 1/8 diluted AX serum. On the basis of absorption capacity per cell, autologous SK-RC- 
7 and allogeneic SK-RC-4 renal cancers express comparable amounts of antigen. Astroeytoma AJ 
significantly reduced  AX reactivity  at  the  highest cell  number tested, in  contrast  to  little  or  no 
absorption by DM normal kidney or VERO cells. 
quantitative absorption analysis of the preabsorbed AX serum. Astrocytoma AJ does 
not absorb any further reactivity over the range of cell numbers tested. Autologous 
renal cancer cells showed significant absorption with 0.12  X  10  6 cells and complete 
absorption with 8  ×  10  6 cells. Absorption with  1.2  X  10  6 SK-RC-9 cells reduces AX 
reactivity by approximately one-half: increasing the number of SK-RC-9 cells by a 
factor of four does not reduce reactivity further. This absorption analysis of AX sera 
indicates  that  at  least  three determinants  are detected  by the reactions of AX sera 
with  autologous  renal  cancer cells.  The complete set  is  shared  with  SK-RC-4,  the 
allogeneic renal cancer that completely absorbs autologous AX reactivity. Cells that 
show a fixed partial absorption lack one (SK-RC-9) or more (astrocytoma A  J) of these 
determinants. 
Autologous Typing of Renal Cancer: Summary of Results.  Table V summarizes the results 
of autologous typing of cultured  renal cancer cells from six patients.  In addition  to 
the analysis of AG sera by PA assays and AX sera by C3-MHA assays (see above), 
these sera were also analyzed with one other serological assay (C3-MHA in  the case 
of AG and IA in the case of AX). Absorption tests of AX sera gave a similar pattern 
with both C3-MHA and IA assays. Absorption tests of AG sera by C3-MHA assays, 
as compared to PA assays, detected a  broader range of cells, including normal cells, 
showing partial or complete absorption of autologous reactivity. Complete absorption 
of autologous reactivity of AB and AE sera was found with certain allogeneic renal 
cancer cells, resembling in this respect the reactions of AX sera rather than AG sera. 
(No allogeneic renal cancer showed complete absorption of autologous reactivity of 
AG sera tested by PA assays, see above). A  comparison of the capacity of different 
allogeneic renal cancer cells to absorb autologous reactivity of AB, AE, AG, and AX 
sera indicates the detection of different sets of determinants in each of these autologous 576  CELL  SURFACE  ANTIGENS  OF  HUMAN  RENAL  CANCER 
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Fro.  8.  Qualitative absorption tests of AX sera preabsorbed with astroctyoma AJ. Undiluted AX 
serum was first  absorbed with an equal volume of packed astrocytoma AJ cells.  Aliquots of this 
preabsorbed serum (diluted 1/4) were further absorbed with the cell types indicated and retested 
for residual C3-MHA reactivity for autologous SK-RC-7 cells. SK-RC-7 and SK-RC-9 showed the 
expected complete and partial absorption, respectively, of AX reactivity. Astrocytoma AJ absorbed 
no further reactivity from preabsorbed AX serum. 
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FIG. 9.  Quantitative absorption  analysis of AX  serum  preabsorbed  with  astrocytoma  AJ  (see 
legend, Fig. 8). Aliquots of preabsorbed 1/3 diluted AX serum were further absorbed with counted 
cell  numbers of the  tumor  indicated. The  dotted  line represents reactivity of preabsorbed  1/3 
diluted AX serum without further absorption. 8.0  ×  106 SK-RC-7 cells absorbed autologous AX 
reactivity completely. 1.25-5  ×  10  n SK-RC-9 cells showed a fixed partial reduction of AX reactivity. 
Absorption with astrocytoma AJ did not cause a further reduction of AX reactivity. 
systems. The  autologous reactivity of sera from two other patients, AR  and  BM,  was 
completely  absorbed  by a  variety of cell  types,  both  normal  and  malignant,  and  in 
the case of AR, even monkey  kidney cells absorbed  autologous  reactivity. 
In terms of classifying the antigens recognized by autologous typing of renal cancer 
cells, AR  and  BM  sera detect class 3  antigens, as indicated  by the capacity  of normal RYUZO  UEDA  ET  AL.  577 
TAnLE  V 
Cell Surface Antigens of Cultured Human Renal Cancers Defined by Absorption Tests with Autologous Sera 
Patieixt ..................  AG  AG  AX  AX  AB*  AE  BM  AR 
Serological  assay  .............  PA  C3-MHA  C3-MHA  IA  C3-MHA  C3-MHA  C3-MHA  C3-MHA 
Absorbed with: 
Autologous  cells: 
Renal  cancer  +  +  +  + 
Fibroblasts  .... 
Allogeneic  cells: 
Renal  cancer  P  or -  +  or P  +,  P  or -  +,  P  or - 
Normal  kidney  --  P  -  -- 
Fibroblasts  -  P  -  - 
Nonrenal  cancer  P  or -  +,  P  or -  P  or -  P  or - 
Fetal  kidney  P  -  - 
Fetal  fibroblasts  - 
Erythrocytes  .... 
Xenogeneic  cells and 
serum: 
Monkey  kidney  --  P  -  - 
Rat  kidney 
Sheep  erythrocytes  .... 
Fetal  bovine  serum  .... 
Class of antigen  1, 2  3  2  2 
+  +  +  + 
--  _  p 
+,  Por--  +,  Por-  +orP  + 
-  -  +  orP 
-  --  +  orP 
Por-  Por-  +,Por-  +  orP 
-  p 
_  _  p 
--  --  P  or  --  + 
2  2  3  3 
+,  complete  absorption;  P, partial  absorption;  -,  no  absorption. 
* Cultured  autologous  normal  kidney  cells were available  for absorption  tests;  no absorption  of autologous  serum 
reactivity  for AB renal  cancer  cells was observed. 
cells to absorb autologous reactivity. AB, AE, and AX sera detect a  range of class 2 
antigens,  as  indicated  by partial  or complete  absorption  with  renal  and  nonrenal 
cancer cells, but not by normal cells. AG sera, analyzed by PA assays, detect both a 
class 1 antigen (restricted to autologous cancer cells) and class 2 antigens (shared with 
certain allogeneic cancer cells). By C3-MHA assays, however, AG sera show predom- 
inantly class 3 reactivity. 
Discussion 
The pattern of reactivity of autologous sera with cultured renal cancer cells observed 
in the present study shows a  general similarity to our past findings with melanoma 
(I-3), leukemia  (4),  and astroeytoma (5).  It seems likely that  a  similar pattern will 
emerge as other tumor types are analyzed in the same way. Before this can be done, 
however, particularly in the case of some of the most common human malignancies 
such as breast and lung, our ability to propagate these cancers in vitro will have to be 
improved. The culturing of the corresponding normal cell type is another challenge 
that will need to be met before the general significance of humoral immune reactions 
to  autologous  tumor  cells  can  be evaluated.  With  regard  to  the  four  tumor  types 
(melanoma, leukemia, astrocytoma, and renal cancer)  that have now been analyzed 
by  autologous  typing,  the  corresponding  normal  cell  population  is  most  readily 
available  in  the  case  of renal  cancer.  How  closely  related  the  cells  cultured  from 
normal kidney and the cells cultured from renal cancer are to one another remains to 
be determined, but quite clearly, epithelial cells derived from normal kidney represent 
a  far more relevant cell population than  fibroblasts or EBV-transformed B-lympho- 578  CELL SURFACE ANTIGENS OF  HUMAN RENAL CANCER 
blast lines, two cell types that are commonly used as control cells in the serological 
study  of human  cancers.  Despite  vigorous  initial  growth,  normal  kidney  cells  can 
rarely be passaged more than  four to five times and this restricted  growth potential 
limits  their  usefulness.  This  behavior of normal  kidney cells  in  culture  most  likely 
reflects exhaustion of required growth factors, a possibility we are now exploring. 
By  testing autologous combinations  of tumor cells and  sera,  the contribution  of 
conventional alloantibody to HLA and AB products can be excluded.  Nevertheless, 
there  still  remains  a  complex  array  of antibodies  recognizing  cell  surface  antigens 
expressed by renal cancer cells. Similar to our findings with melanoma and astrocy- 
toma, absorption analysis revealed three classes of renal cancer antigens detected by 
autologous sera; class  1 antigens, restricted to the autologous tumor; class 2 antigens, 
shared by certain allogeneic tumors of renal  as well as nonrenal  origin;  and class 3 
antigens, expressed by normal as well as malignant cells. The serum of one patient 
(AG) had antibodies to class 1, 2, and 3 antigens; other patients showed predominantly 
class  2  (e.g.,  AX)  or  class  3  (e.g.,  AR)  reactivity  by  autologous  typing.  Partial 
absorption of autologous reactivity with certain aliogeneic cancer cells was a consistent 
feature  in  the  analysis  of sera  from  renal  cancer  patients  with  class  1  or  class  2 
reactivity. This could be a result of a  lower quantity of antigen on the allogeneic cell 
or to a  qualitatively different spectrum of antigens expressed by the autologous and 
allogeneic cell. Quantitative absorptions and double absorptions are useful in distin- 
guishing  between  these  two  possibilities.  In  the  two cases studied  most  extensively 
(AG and AX), partial absorption was found to be a  result of allogeneic cells lacking 
one or more of the determinants detected by autologous sera on the autologous target 
cell.  Another  possibility to account  for results  simulating partial  absorption  is  that 
complexes  of antigen  and  antibody  are  released  from  the  cell  surface  during  the 
absorption procedure and remain in the supernate after removing the absorbing cells 
by centrifugation.  These complexes may bind to target cells because they are more 
sticky or because one of the antibody combining sites is free. Although this remains a 
theoretical  possibility,  we  have  not  detected  any  difference  in  the  reactivity  of 
absorbed sera after differential ultracentifugation  to remove antigen/antibody com- 
plexes. 
The frequency of antibody to class 2 antigens in patients with renal cancer is higher 
than  in our corresponding studies of patients with melanoma, leukemia, and astro- 
cytoma.  As  the  detection  of class  2  antigens  may  be  obscured  by  higher  titered 
antibody to class 3 antigens, it is possible that class 2 reactivity to these other cancers 
is more prevalent than presently recognized. In the study of experimental tumors, the 
finding of class 2 antigens raises the suspicion of virus-coded or virus-related antigens 
and this possibility is being explored with  regard to renal cancer by absorbing sera 
detecting  class  2  antigens  with  cells  infected  with  viruses  suspected  of having  an 
association with human cancer, e.g., papovaviruses, herpesviruses, and oncornaviruses. 
Another  clue  that  may  link  class  2  antigens  to  a  virus  is  the  presence of natural 
antibody to surface antigens  of renal  cancer cells in  the sera of apparently normal 
individuals  (L. Li, unpublished  observations). The reactivity of such sera is removed 
by renal cancer cells, but  not  by normal kidney,  fetal kidney,  or a  variety of other 
normal or malignant cells. Thus, the renal cancer antigens detected by certain normal 
human sera appear to resemble in  part  the class 2  antigens  detected  by autologous 
typing. Whether these natural  antibodies  recognize the same range of class 2 deter- 
minants as sera from renal cancer patients remains to be determined. RYUZO UEDA ET AL.  579 
Summary 
Sera  from  28  patients  with  renal  cancer  were  tested  for reactivity with  surface 
antigens of cultured autologous renal cancer cells.  Four serological assays were used 
to survey sera for autologous antibody. Immune adherence, protein A, and C3-mixed 
hemadsorption assays detected reactivity in a high percentage of patients (80-100%), 
whereas mixed hemadsorption assays were negative with sera from all but one patient. 
Reactive sera from six patients were analyzed by absorption  tests with autologous, 
allogeneic,  and  xenogeneic  normal  and  malignant  cells.  The  absorption  analysis 
indicated the detection of three classes of surface antigens by autologous sera: class 1 
antigens, restricted to autologous renal cancer cells; class 2 antigens, present on certain 
allogeneic  renal  and  nonrenal  cancer cells;  and  class  3  antigens,  found  on  a  wide 
variety of normal and malignant cell types. The sera of one patient detected class  l, 
2, and 3 antigens, the sera of three patients detected class 2 antigens, and the sera of 
two  patients  detected  class  3  antigens.  This  analysis  of  renal  cancer,  with  the 
recognition of three classes of surface antigens recognized by autologous sera, resembles 
the  results  of  autologous  typing  of  three  other  human  malignancies:  malignant 
melanoma, acute leukemia, and astrocytoma. Evidence provided by autologous typing 
of these cancers indicates that class  1 and class 2 antigens are tumor-restricted and 
that under certain circumstances these antigens are immunogenic for the autologous 
host. 
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